The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Parkinson’s disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures
Open accessAbstract
Sequence variants at or near the leucine-rich repeat kinase 2 (LRRK2) locus have been associated with susceptibility to three human conditions: Parkinson's disease (PD), Crohn’s disease and leprosy. As all three disorders represent complex diseases with evidence of inflammation, we hypothesized a role for LRRK2 in immune cell functions. Here, we report that full-length Lrrk2 is a relatively common constituent of human peripheral blood mononuclear cells (PBMC) including affinity isolated, CD14+ monocytes, CD19+ B cells, and CD4+ as well as CD8+ T cells. Up to 26% of PBMC from healthy donors and up to 43% of CD14+ monocytes were stained by anti-Lrrk2 antibodies using cell sorting. PBMC lysates contained full-length (>260 kDa) and higher molecular weight Lrrk2 species. The expression of LRRK2 in circulating leukocytes was confirmed by microscopy of human blood smears and in sections from normal midbrain and distal ileum. Lrrk2 reactivity was also detected in mesenteric lymph nodes and spleen (including in dendritic cells), but was absent in splenic mononuclear cells from lrrk2-null mice, as expected. In cultured bone marrow-derived macrophages from mice we made three observations: (i) a predominance of higher molecular weight lrrk2; (ii) the reduction of autophagy marker LC3-II in R1441Clrrk2-mutant cells (<31%); and (iii) a significant up-regulation of lrrk2 mRNA (>fourfold) and protein after exposure to several microbial structures including bacterial lipopolysaccharide and lentiviral particles. We conclude that Lrrk2 is a constituent of many cell types in the immune system. Following the recognition of microbial structures, stimulated macrophages respond with altered lrrk2 gene expression. In the same cells, lrrk2 appears to co-regulate autophagy. A pattern recognition receptor-type function for LRRK2 could explain its locus' association with Crohn’s disease and leprosy risk. We speculate that the role of Lrrk2 in immune cells may also be relevant to the susceptibility of developing PD or its progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease
Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., et al. (2001) · Nature · doi:10.1038/35079114 · Cited by 5,030
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R. J., Calne, D. B., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.005 · Cited by 3,005
Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease
the NIDDK IBD Genetics Consortium, Barrett, J. C., the Belgian-French IBD Consortium, the Wellcome Trust Case Control Consortium, Hansoul, S., Nicolae, D. L., Cho, J. H., Duerr, R. H., Rioux, J. D., Brant, S. R., et al. (2008) · Nature Genetics · doi:10.1038/ng.175 · Cited by 2,593
Neuroinflammation in Parkinson’s disease: A target for neuroprotection?
Hirsch, E. C., & Hunot, S. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70062-6 · Cited by 1,984
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Simón-Sánchez, J., Schulte, C., Bras, J. M., Sharma, M., Gibbs, J. R., Berg, D., Paisan-Ruiz, C., Lichtner, P., Scholz, S. W., Hernandez, D. G., et al. (2009) · Nature Genetics · doi:10.1038/ng.487 · Cited by 1,751
Braak, H., R�b, U., Gai, W. P., & Del Tredici, K. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0808-2 · Cited by 1,683
Travassos, L. H., Carneiro, L. A. M., Ramjeet, M., Hussey, S., Kim, Y.-G., Magalhães, J. G., Yuan, L., Soares, F., Chea, E., Le Bourhis, L., et al. (2010) · Nature Immunology · doi:10.1038/ni.1823 · Cited by 1,306
Self-citationParkinson's disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity
West, A. B., Moore, D. J., Biskup, S., Bugayenko, A., Smith, W. W., Ross, C. A., Dawson, V. L., & Dawson, T. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507360102 · Cited by 1,228
Brochard, V., Combadière, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J.-M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36470 · Cited by 1,172
Genomewide Association Study of Leprosy
Zhang, F.-R., Huang, W., Chen, S.-M., Sun, L.-D., Liu, H., Li, Y., Cui, Y., Yan, X.-X., Yang, H.-T., Yang, R.-D., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903753 · Cited by 1,031
Nod2 Mutation in Crohn's Disease Potentiates NF-κB Activity and IL-1ß Processing
Maeda, S., Hsu, L.-C., Liu, H., Bankston, L. A., Iimura, M., Kagnoff, M. F., Eckmann, L., & Karin, M. (2005) · Science · doi:10.1126/science.1103685 · Cited by 749
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson’s disease
Neumann, J., Bras, J., Deas, E., O'Sullivan, S. S., Parkkinen, L., Lachmann, R. H., Li, A., Holton, J., Guerreiro, R., Paudel, R., et al. (2009) · Brain · doi:10.1093/brain/awp044 · Cited by 696
LRRK2 G2019S as a Cause of Parkinson's Disease in Ashkenazi Jews
Ozelius, L. J., Senthil, G., Saunders-Pullman, R., Ohmann, E., Deligtisch, A., Tagliati, M., Hunt, A. L., Klein, C., Henick, B., Hailpern, S. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmc055509 · Cited by 665
The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease
Cookson, M. R. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2935 · Cited by 539
Toll‐like receptor 2‐dependent bacterial sensing does not occur via peptidoglycan recognition
Travassos, L. H., Girardin, S. E., Philpott, D. J., Blanot, D., Nahori, M., Werts, C., & Boneca, I. G. (2004) · EMBO reports · doi:10.1038/sj.embor.7400248 · Cited by 504
Self-citationTong, Y., Yamaguchi, H., Giaime, E., Boyle, S., Kopan, R., Kelleher, R. J., & Shen, J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004676107 · Cited by 501
Self-citationLRRK2 in Parkinson's disease: protein domains and functional insights
Mata, I. F., Wedemeyer, W. J., Farrer, M. J., Taylor, J. P., & Gallo, K. A. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.03.006 · Cited by 489
Manipulation of Host Cell Death Pathways during Microbial Infections
Lamkanfi, M., & Dixit, V. M. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.06.007 · Cited by 454
Alegre-Abarrategui, J., Christian, H., Lufino, M. M. P., Mutihac, R., Venda, L. L., Ansorge, O., & Wade-Martins, R. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp346 · Cited by 432
LRRK2 Is Involved in the IFN-γ Response and Host Response to Pathogens
Gardet, A., Benita, Y., Li, C., Sands, B. E., Ballester, I., Stevens, C., Korzenik, J. R., Rioux, J. D., Daly, M. J., Xavier, R. J., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000548 · Cited by 415
Parkin Localizes to the Lewy Bodies of Parkinson Disease and Dementia with Lewy Bodies
Schlossmacher, M. G., Frosch, M. P., Gai, W. P., Medina, M., Sharma, N., Forno, L., Ochiishi, T., Shimura, H., Sharon, R., Hattori, N., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61113-3 · Cited by 325
Self-citationPeripheral Inflammatory Biomarkers and Risk of Parkinson's Disease
Chen, H., O'Reilly, E. J., Schwarzschild, M. A., & Ascherio, A. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm260 · Cited by 317
Involvement of Interferon-γ in Microglial-Mediated Loss of Dopaminergic Neurons
Mount, M. P., Lira, A., Grimes, D., Smith, P. D., Faucher, S., Slack, R., Anisman, H., Hayley, S., & Park, D. S. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5321-06.2007 · Cited by 315
Self-citationR1441C mutation in LRRK2 impairs dopaminergic neurotransmission in mice
Tong, Y., Pisani, A., Martella, G., Karouani, M., Yamaguchi, H., Pothos, E. N., & Shen, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906334106 · Cited by 304
Self-citationSaïd-Sadier, N., Padilla, E., Langsley, G., & Ojcius, D. M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010008 · Cited by 303
Cullen, V., Sardi, S. P., Ng, J., Xu, Y., Sun, Y., Tomlinson, J. J., Kolodziej, P., Kahn, I., Saftig, P., Woulfe, J., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22400 · Cited by 303
Self-citationCathepsin D expression level affects alpha-synuclein processing, aggregation, and toxicity in vivo
Cullen, V., Lindfors, M., Ng, J., Paetau, A., Swinton, E., Kolodziej, P., Boston, H., Saftig, P., Woulfe, J., Feany, M. B., et al. (2009) · Molecular Brain · doi:10.1186/1756-6606-2-5 · Cited by 279
Self-citationLeucine-Rich Repeat Kinase 2 Mutations and Parkinson's Disease: Three Questions
Greggio, E., & Cookson, M. R. (2009) · ASN Neuro · doi:10.1042/an20090007 · Cited by 272
GATA transcription factors directly regulate the Parkinson's disease-linked gene α-synuclein
Scherzer, C. R., Grass, J. A., Liao, Z., Pepivani, I., Zheng, B., Eklund, A. C., Ney, P. A., Ng, J., McGoldrick, M., Mollenhauer, B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802437105 · Cited by 270
Self-citationThe Genetics of Crohn's Disease
Van Limbergen, J., Wilson, D. C., & Satsangi, J. (2009) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-082908-150013 · Cited by 260
Berger, Z., Smith, K. A., & LaVoie, M. J. (2010) · Biochemistry · doi:10.1021/bi100157u · Cited by 213
Self-citationParkinson disease, 10 years after its genetic revolution: Multiple clues to a complex disorder
Klein, C., & Schlossmacher, M. G. (2007) · Neurology · doi:10.1212/01.wnl.0000271880.27321.a7 · Cited by 211
Self-citationTo Nibble at Plant Resistance Proteins
Takken, F. L. W., & Tameling, W. I. L. (2009) · Science · doi:10.1126/science.1171666 · Cited by 195
Venderova, K., Kabbach, G., Abdel-Messih, E., Zhang, Y., Parks, R. J., Imai, Y., Gehrke, S., Ngsee, J., LaVoie, M. J., Slack, R. S., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp394 · Cited by 184
Self-citationLRRK2 Expression in Normal and Pathologic Human Brain and in Human Cell Lines
Miklossy, J., Arai, T., Guo, J.-P., Klegeris, A., Yu, S., McGeer, E. G., & McGeer, P. L. (2006) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000235121.98052.54 · Cited by 182
LRRK2 expression linked to dopamine‐innervated areas
Galter, D., Westerlund, M., Carmine, A., Lindqvist, E., Sydow, O., & Olson, L. (2006) · Annals of Neurology · doi:10.1002/ana.20808 · Cited by 174
DJ-1 protects the nigrostriatal axis from the neurotoxin MPTP by modulation of the AKT pathway
Aleyasin, H., Rousseaux, M. W. C., Marcogliese, P. C., Hewitt, S. J., Irrcher, I., Joselin, A. P., Parsanejad, M., Kim, R. H., Rizzu, P., Callaghan, S. M., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914876107 · Cited by 168
Self-citationThe Parkinson Disease Gene LRRK2: Evolutionary and Structural Insights
Marín, I. (2006) · Molecular Biology and Evolution · doi:10.1093/molbev/msl114 · Cited by 165
Dynamic and redundant regulation of LRRK2 and LRRK1 expression
Biskup, S., Moore, D. J., Rea, A., Lorenz-Deperieux, B., Coombes, C. E., Dawson, V. L., Dawson, T. M., & West, A. B. (2007) · BMC Neuroscience · doi:10.1186/1471-2202-8-102 · Cited by 158
Evaluation of LRRK2 G2019S penetrance
Goldwurm, S., Zini, M., Mariani, L., Tesei, S., Miceli, R., Sironi, F. M., Clementi, M., Bonifati, V., & Pezzoli, G. (2007) · Neurology · doi:10.1212/01.wnl.0000254483.19854.ef · Cited by 132
Leucine-Rich Repeat Kinase 2 Gene-Associated Disease: Redefining Genotype-Phenotype Correlation
Wider, C. W., Dickson, D. W., & Wszołek, Z. K. (2010) · Neurodegenerative Diseases · doi:10.1159/000289232 · Cited by 128
Transcriptional profile of Parkinson blood mononuclear cells with LRRK2 mutation
Mutez, E., Larvor, L., Leprêtre, F., Mouroux, V., Hamalek, D., Kerckaert, J., Pérez‐Tur, J., Waucquier, N., Vanbesien-Mailliot, C., Duflot, A., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.10.016 · Cited by 116
LRRK2: a common pathway for parkinsonism, pathogenesis and prevention?
Taylor, J. P., Mata, I. F., & Farrer, M. J. (2006) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.12.004 · Cited by 108
Inflammasome Inhibition as a Pathogenic Stealth Mechanism
Taxman, D. J., Huang, M. T.-H., & Ting, J. P. ‐. (2010) · Cell Host & Microbe · doi:10.1016/j.chom.2010.06.005 · Cited by 96
Genetic dissection of immunity in leprosy
Alcaïs, A., Mira, M. T., Casanova, J., Schurr, E., & Abel, L. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.11.006 · Cited by 90
Nod1 and Nod2 induce CCL5/RANTES through the NF‐κB pathway
Werts, C., Bourhis, L. L., Liu, J., et al. (2007) · European Journal of Immunology · doi:10.1002/eji.200737069 · Cited by 89
Peripheral Chemo-Cytokine Profiles in Alzheimers and Parkinsons Diseases
Reale, M., Greig, N., & Kamal, M. (2009) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955709789055199 · Cited by 82
A Common Genetic Fingerprint in Leprosy and Crohn's Disease?
Schurr, E., & Gros, P. (2009) · New England Journal of Medicine · doi:10.1056/nejme0910690 · Cited by 78
Bourhis, L. L., Magalhaes, J. G., Selvanantham, T., Travassos, L. H., Geddes, K., Fritz, J. H., Viala, J., Tedin, K., Girardin, S. E., & Philpott, D. J. (2009) · Infection and Immunity · doi:10.1128/iai.00519-09 · Cited by 56
Self-citationAge-dependent and cell-population-restricted LRRK2 expression in normal mouse spleen
Maekawa, T., Kubo, M., Yokoyama, I., Ohta, E., & Obata, F. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.01.041 · Cited by 52
Bourhis, L. L., Magalhaes, J. G., Selvanantham, T., Travassos, L. H., Geddes, K., Fritz, J. H., Viala, J., Tedin, K., Girardin, S. E., & Philpott, D. J. (2009) · Infection and Immunity · doi:10.1128/iai.01067-09 · Cited by 49
Self-citationSchurr, E., Alcaïs, A., de Léséleuc, L., & Abel, L. (2006) · Seminars in Immunology · doi:10.1016/j.smim.2006.07.005 · Cited by 48
Update on the Functional Biology of Lrrk2
Melrose, H. L. (2008) · Future Neurology · doi:10.2217/14796708.3.6.669 · Cited by 41
LRRK2 is expressed in B-2 but not in B-1 B cells, and downregulated by cellular activation
Kubo, M., Kamiya, Y., Nagashima, R., Maekawa, T., Eshima, K., Azuma, S., Ohta, E., & Obata, F. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.07.021 · Cited by 41
IL-7-dependent STAT-5 activation and CD8+ T cell proliferation are impaired in HIV infection
Vranjkovic, A., Crawley, A. M., Patey, A. M., & Angel, J. B. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0710430 · Cited by 35
Self-citationα-Synuclein and LRRK2: Partners in Crime
Tong, Y., & Shen, J. (2009) · Neuron · doi:10.1016/j.neuron.2009.12.017 · Cited by 27
Self-citationParkinson's Disease: Assays for the Ubiquitin Ligase Activity of Neural Parkin
Schlossmacher, M. G., & Shimura, H. (2005) · Humana Press eBooks · doi:10.1385/1-59259-895-1:351 · Cited by 19
Self-citationTranslational Research in Neurology and Neuroscience 2011: Movement Disorders
Klein, C., Krainc, D., Schlossmacher, M. G., & Lang, A. E. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.11 · Cited by 14
Self-citation
Cited by
Neuroinflammation in Parkinson's disease and its potential as therapeutic target
Wang, Q., Liu, Y., & Zhou, J. (2015) · Translational Neurodegeneration · doi:10.1186/s40035-015-0042-0 · Cited by 884
LRRK2 Inhibition Attenuates Microglial Inflammatory Responses
Moehle, M. S., Webber, P. J., Tse, T., Sukar, N., Standaert, D. G., DeSilva, T. M., Cowell, R. M., & West, A. B. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.5601-11.2012 · Cited by 463
The Role of Innate and Adaptive Immunity in Parkinson's Disease
Kannarkat, G. T., Boss, J. M., & Tansey, M. G. (2013) · Journal of Parkinson’s Disease · doi:10.3233/jpd-130250 · Cited by 324
α-Synuclein pathology in Parkinson’s disease and related α-synucleinopathies
Henderson, M. X., Trojanowski, J. Q., & Lee, V. M.-Y. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.134316 · Cited by 291
LRRK2 levels in immune cells are increased in Parkinson’s disease
Cook, D. A., Kannarkat, G. T., Cintron, A. F., Butkovich, L. M., Fraser, K. B., Chang, J., Grigoryan, N., Factor, S. A., West, A. B., Boss, J. M., et al. (2017) · npj Parkinson's Disease · doi:10.1038/s41531-017-0010-8 · Cited by 279
Metadata
- Authors
- Hakimi, M., Selvanantham, T., Swinton, E., Padmore, R. F., Tong, Y., Kabbach, G., Venderova, K., Girardin, S. E., Bulman, D. E., Scherzer, C. R., LaVoie, M. J., Gris, D., Park, D. S., Angel, J. B., Shen, J., Philpott, D. J., & Schlossmacher, M. G.
- Venue
- Journal of Neural Transmission
- Published
- 2011-05
- Volume
- 118
- Issue
- 5
- Pages
- 795-808
- ISSN
- 0300-9564 (ISSN-L)
- 1435-1463
- OpenAlex
- W2076888837
- Cited by
- 283
- References
- 58
- FWCI
- 12.07
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.